Differenze

Queste sono le differenze tra la revisione selezionata e la versione attuale della pagina.

--- aree:proteomica:rppa:bibliografia [2017/01/19 20:07]
127.0.0.1 modifica esterna
+++ aree:proteomica:rppa:bibliografia [2017/02/18 22:41] (versione attuale)
Gianluca Frustagli
@@ Linea 1: / Linea 1: @@
 **Area Proteomica**
-====== LC-MS/MS ======
+====== RPPA ======
-<wrap button>[[:aree:proteomica:lc-ms_ms:richiesta|Richiesta servizio]] [[:aree:proteomica:lc-ms_ms:protocolli|Protocolli]] [[:aree:proteomica:lc-ms_ms:bibliografia|Bibliografia]] [[:aree:proteomica:lc-ms_ms:faq|FAQ]]</wrap>
+<WRAP tabs>
+  * [[:aree:proteomica:rppa:richiesta|Richiesta servizio]]
+  * [[:aree:proteomica:rppa:protocolli|Protocolli]]
+  * [[:aree:proteomica:rppa:bibliografia|Bibliografia]]
+  * [[:aree:proteomica:rppa:link_tutorial|Link & Tutorial]]
+  * [[:aree:proteomica:rppa:faq|FAQ]]
+</WRAP>
 ===== Bibliografia =====
-  * //[[http://www.sciencedirect.com/science/article/pii/S0003269702956770|Intact glucosinolate analysis in plant extracts by programmed cone voltage electrospray LC/MS: performance and comparison with LC/MS/MS methods]]// - FA Mellon, RN Bennett, B Holst, G Williamson - **Analytical Biochemistry, 2002** - Elsevier
+Signore M et al. \\
+[[https://www.ncbi.nlm.nih.gov/pubmed/27286453|UCN-01 enhances cytotoxicity of irinotecan in colorectal cancer stem-like cells by impairing DNA damage response.]] \\
+<wrap lo>Oncotarget. 2016 Jul 12;7(28):44113-44128. doi: 10.18632/oncotarget.9859.</wrap>
-  * //[[http://www.sciencedirect.com/science/article/pii/S0003269798928093|Protein identification at the low femtomole level from silver-stained gels using a new fritless electrospray interface for liquid chromatography–microspray and …]]// - CL Gatlin, GR Kleemann, LG Hays, AJ Link… - **Analytical biochemistry, 1998** - Elsevier
+De Angelis ML et al. \\
+[[https://www.ncbi.nlm.nih.gov/pubmed/26956206|Cancer Stem Cell-Based Models of Colorectal Cancer Reveal Molecular Determinants of Therapy Resistance.]] \\
+<wrap lo>Stem Cells Transl Med. 2016 Apr;5(4):511-23. doi: 10.5966/sctm.2015-0214.</wrap>
-  * //[[http://www.sciencedirect.com/science/article/pii/S1044030503005749|Matrix effect in bio-analysis of illicit drugs with LC-MS/MS: influence of ionization type, sample preparation, and biofluid]]// - R Dams, MA Huestis, WE Lambert… - **Journal of the American …, 2003** - Elsevier
+Marziali G, Signore M et al. \\
+[[https://www.ncbi.nlm.nih.gov/pubmed/26857460|Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes With Different Clinical Outcome.]] \\
+<wrap lo>Sci Rep. 2016 Feb 9;6:21557. doi: 10.1038/srep21557.</wrap>
-  * //[[http://www.sciencedirect.com/science/article/pii/S0003269796903139|Selective detection and sequencing of phosphopeptides at the femtomole level by mass spectrometry]]// - SA Carr, MJ Huddleston, RS Annan - **Analytical biochemistry, 1996** - Elsevier
+Trono P et al. \\
+[[https://www.ncbi.nlm.nih.gov/pubmed/25961924|hMENA(11a) contributes to HER3-mediated resistance to PI3K inhibitors in HER2-overexpressing breast cancer cells.]] \\
+<wrap lo>Oncogene. 2016 Feb 18;35(7):887-96. doi: 10.1038/onc.2015.143. Epub 2015 May 11.</wrap>
+Signore M et al. \\
+[[https://www.ncbi.nlm.nih.gov/pubmed/24810059|Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo.]] \\
+<wrap lo>Cell Death Dis. 2014 May 8;5:e1223. doi: 10.1038/cddis.2014.188.</wrap>
+Forte S et al. \\
+[[https://www.ncbi.nlm.nih.gov/pubmed/24349068|Gene expression analysis of PTEN positive glioblastoma stem cells identifies DUB3 and Wee1 modulation in a cell differentiation model.]] \\
+<wrap lo>PLoS One. 2013 Dec 12;8(12):e81432. doi: 10.1371/journal.pone.0081432.</wrap>
+Sette G et al. \\
+[[https://www.ncbi.nlm.nih.gov/pubmed/23056514|EGFR inhibition abrogates leiomyosarcoma cell chemoresistance through inactivation of survival pathways and impairment of CSC potential.]] \\
+<wrap lo>PLoS One. 2012;7(10):e46891. doi: 10.1371/journal.pone.0046891.</wrap>
+Francescangeli F et al. \\
+[[https://www.ncbi.nlm.nih.gov/pubmed/22753241|Proliferation state and polo-like kinase1 dependence of tumorigenic colon cancer cells.]] \\
+<wrap lo>Stem Cells. 2012 Sep;30(9):1819-30. doi: 10.1002/stem.1163.</wrap>
+Signore M, Reeder KA. \\
+[[https://www.ncbi.nlm.nih.gov/pubmed/22081344|Antibody validation by Western blotting.]] \\
+<wrap lo>Methods Mol Biol. 2012;823:139-55. doi: 10.1007/978-1-60327-216-2_10.</wrap>
+Napoletani D et al. \\
+[[https://www.ncbi.nlm.nih.gov/pubmed/21439301|Homologous control of protein signaling networks.]] \\
+<wrap lo>J Theor Biol. 2011 Jun 21;279(1):29-43. doi: 10.1016/j.jtbi.2011.03.020.</wrap>
+VanMeter A, Signore M, Pierobon M, Espina V, Liotta LA, Petricoin EF 3rd. \\
+[[https://www.ncbi.nlm.nih.gov/pubmed/17892368|Reverse-phase protein microarrays: application to biomarker discovery and translational medicine.]] \\
+<wrap lo>Expert Rev Mol Diagn. 2007 Sep;7(5):625-33. Review.</wrap>
+Spreafico F et al. \\
+Proteomics analysis of cerebrospinal fluid from children with Central Nervous System tumors identifies candidate proteins relating to tumor metastatic spread. \\
+<wrap lo em>Oncotarget (submitted, second round of revision)</wrap>
+Manic G & Signore M et al. \\
+CHK1-targeted therapy to deplete DNA replication-stressed, p53-deficient hyperdiploid colorectal cancer stem cells. \\
+<wrap lo em>Gut (submitted, second round of revision)</wrap>
+Haas TL et al. \\
+Identification of Integrin Alpha 7 as Functional Marker and Potential Therapeutic Target in Glioblastoma Multiforme. \\
+<wrap lo em>Cell Stem Cell (submitted, second round of revision)</wrap>